{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:20:10Z","timestamp":1781374810682,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000991","name":"Faculty of Medicine, Nursing and Health Sciences, Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000991","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>A cute myeloid leukaemia (AML) carries major clinical, economic, and psychosocial burdens. Supportive care is critical to prevent mortality and morbidity and support long-term well-being. Many AML trials focus on treating AML disease, but few prospectively evaluate supportive care measures. This study sought to identify AML supportive care research priorities to inform the design of future AML clinical trials.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A three-stage online Delphi process was used. Participants (clinicians and people with lived experience) were invited from Australia and New Zealand through the Australasian Leukaemia and Lymphoma Group (ALLG), the Leukaemia Foundation, and professional networks. Round 1 generated supportive care research question, and in round 2, participants rated each question\u2019s importance. A priori criteria were applied for a question to continue to round three. Finally, participants ranked their top 10 research questions and the type of research needed to address each question.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 31 participants completed round one, and 22 in rounds two and three. People with lived experience made up 32% of the sample in round one, 45% in round two, and 27% in round three. Round one resulted in 66 research questions across 13 domains. In round two, from the initial 66 questions, 16 (24%) met the criteria to progress to the next round. In the final round, participants agreed on 10 priority research questions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This Delphi process identified ten supportive care research priorities in AML across many domains, including infection management, bleeding prevention, nutrition, exercise, and frailty assessments. This work, which incorporates people with lived experience, can be used to inform design of future AML trials.\n<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09888-7","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:05:56Z","timestamp":1757574356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Research priorities to address supportive care needs in acute myeloid leukaemia (AML)\u2014results from a Delphi survey"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6500-3075","authenticated-orcid":false,"given":"Catriona","family":"Parker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Weinkove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe K","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"3","key":"9888_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H Dohner","year":"2010","unstructured":"Dohner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al (2010) Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115(3):453\u2013474","journal-title":"Blood"},{"issue":"5","key":"9888_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000529595","volume":"50","author":"L Miller","year":"2023","unstructured":"Miller L, Freed-Freundlich M, Shimoni A, Hellou T, Avigdor A, Misgav M et al (2023) Defining current patterns of blood product use during intensive induction chemotherapy in newly diagnosed acute myeloid leukemia patients. Transfus Med Hemother 50(5):456\u2013468","journal-title":"Transfus Med Hemother"},{"issue":"21","key":"9888_CR3","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.1002\/cncr.32397","volume":"125","author":"SD Slavin","year":"2019","unstructured":"Slavin SD, Fenech A, Jankowski AL, Abel GA, Brunner AM, Steensma DP et al (2019) Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission. Cancer 125(21):3845\u20133852","journal-title":"Cancer"},{"issue":"11","key":"9888_CR4","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1080\/03007995.2019.1631149","volume":"35","author":"NL Crossnohere","year":"2019","unstructured":"Crossnohere NL, Richardson DR, Reinhart C, O\u2019Donoghue B, Love SM, Smith BD et al (2019) Side effects from acute myeloid leukemia treatment: results from a national survey. Curr Med Res Opin 35(11):1965\u20131970","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"9888_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.blre.2017.08.010","volume":"32","author":"SA Buckley","year":"2017","unstructured":"Buckley SA, Kirtane K, Walter RB, Lee SJ, Lyman GH (2017) Patient-reported outcomes in acute myeloid leukemia: where are we now? Blood Rev 32(1):81\u201387","journal-title":"Blood Rev"},{"issue":"6","key":"9888_CR6","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3324\/haematol.11987","volume":"93","author":"D Messerer","year":"2008","unstructured":"Messerer D, Engel J, Hasford J, Schaich M, Ehninger G, Sauerland C et al (2008) Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. Haematologica 93(6):826\u2013833","journal-title":"Haematologica"},{"issue":"7","key":"9888_CR7","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0959-8049(03)00628-2","volume":"40","author":"M Watson","year":"2004","unstructured":"Watson M, Buck G, Wheatley K, Homewood JR, Goldstone AH, Rees JKH et al (2004) Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients. Eur J Cancer 40(7):971\u2013978","journal-title":"Eur J Cancer"},{"issue":"1","key":"9888_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0305-7372(03)00142-7","volume":"30","author":"A Redaelli","year":"2004","unstructured":"Redaelli A, Stephens JM, Brandt S, Botteman MF, Pashos CL (2004) Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 30(1):103\u2013117","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"9888_CR9","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1182\/bloodadvances.2019000955","volume":"4","author":"NR Neuendorff","year":"2020","unstructured":"Neuendorff NR, Loh KP, Mims AS, Christofyllakis K, Soo WK, B\u00f6l\u00fckbasi B et al (2020) Anthracycline-related cardiotoxicity in older patients with acute myeloid leukemia: a young SIOG review paper. Blood Adv 4(4):762\u2013775","journal-title":"Blood Adv"},{"issue":"9","key":"9888_CR10","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00277-014-2088-y","volume":"93","author":"E Br\u00e5nvall","year":"2014","unstructured":"Br\u00e5nvall E, Derolf AR, Johansson E, Hultcrantz M, Bergmark K, Bj\u00f6rkholm M (2014) Self-reported fertility in long-term survivors of acute myeloid leukemia. Ann Hematol 93(9):1491\u20131498","journal-title":"Ann Hematol"},{"issue":"79\u201380","key":"9888_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2020.110956","volume":"1","author":"A Van de Louw","year":"2020","unstructured":"Van de Louw A, Zhu X, Frankenfield D (2020) Obesity and malnutrition in critically ill patients with acute myeloid leukemia: prevalence and impact on mortality. Nutrition 1(79\u201380):110956","journal-title":"Nutrition"},{"issue":"3","key":"9888_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009663","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, Wang C, Liu X, Liu Q, Lin H, Liu C et al (2018) Severe malnutrition evaluated by patient-generated subjective global assessment results in poor outcome among adult patients with acute leukemia: a retrospective cohort study. Medicine (Baltimore) 97(3):e9663","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"9888_CR13","first-page":"2435","volume":"23","author":"J Smith-Turchyn","year":"2015","unstructured":"Smith-Turchyn J, Richardson J (2015) A systematic review on the use of exercise interventions for individuals with myeloid leukemia. Support Care Cancer 23(8):2435\u20132446","journal-title":"Support Care Cancer"},{"issue":"2","key":"9888_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jphys.2016.02.012","volume":"62","author":"AM Dennett","year":"2016","unstructured":"Dennett AM, Peiris CL, Shields N, Prendergast LA, Taylor NF (2016) Moderate-intensity exercise reduces fatigue and improves mobility in cancer survivors: a systematic review and meta-regression. J Physiother 62(2):68\u201382","journal-title":"J Physiother"},{"issue":"1","key":"9888_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0163-8343(92)90025-6","volume":"14","author":"GH Mumma","year":"1992","unstructured":"Mumma GH, Mashberg D, Lesko LM (1992) Long-term psychosexual adjustment of acute leukemia survivors: impact of marrow transplantation versus conventional chemotherapy. Gen Hosp Psychiatry 14(1):43\u201355","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"9888_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.21234","volume":"104","author":"CA Meyers","year":"2005","unstructured":"Meyers CA, Albitar M, Estey E (2005) Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer 104(4):788\u2013793","journal-title":"Cancer"},{"issue":"3","key":"9888_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/ejh.12324","volume":"93","author":"A Leunis","year":"2014","unstructured":"Leunis A, Redekop WK, Uyl-de Groot CA, L\u00f6wenberg B (2014) Impaired health-related quality of life in acute myeloid leukemia survivors: a single-center study. Eur J Haematol 93(3):198\u2013206","journal-title":"Eur J Haematol"},{"issue":"6","key":"9888_CR18","doi-asserted-by":"publisher","first-page":"E31","DOI":"10.1097\/NCC.0000000000000428","volume":"40","author":"TA Albrecht","year":"2017","unstructured":"Albrecht TA, Boyiadzis M, Elswick RK, Starkweather A, Rosenzweig M (2017) Symptom management and psychosocial needs of adults with acute myeloid leukemia during induction treatment: a pilot study. Cancer Nurs 40(6):E31\u2013E38","journal-title":"Cancer Nurs"},{"issue":"1","key":"9888_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/cncr.30982","volume":"124","author":"SA Buckley","year":"2018","unstructured":"Buckley SA, Jimenez-Sahagun D, Othus M, Walter RB, Lee SJ (2018) Quality of life from the perspective of the patient with acute myeloid leukemia. Cancer 124(1):145\u2013152","journal-title":"Cancer"},{"issue":"23","key":"9888_CR20","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.1182\/blood.V126.23.4496.4496","volume":"126","author":"TW LeBlanc","year":"2015","unstructured":"LeBlanc TW, Wolf SP, El-Jawahri A, Davis DM, Locke SC, Abernethy A (2015) Symptom burden, quality of life, and distress in acute myeloid leukemia patients receiving induction chemotherapy: results of a prospective electronic patient-reported outcomes study. Blood 126(23):4496\u20134496","journal-title":"Blood"},{"issue":"Supplement 2","key":"9888_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1634\/theoncologist.5-suppl_2-9","volume":"5","author":"GA Curt","year":"2000","unstructured":"Curt GA (2000) The impact of fatigue on patients with cancer: overview of FATIGUE 1 and 2. Oncologist 5(Supplement 2):9\u201312","journal-title":"Oncologist"},{"issue":"1","key":"9888_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40487-016-0039-6","volume":"5","author":"EE Korol","year":"2017","unstructured":"Korol EE, Wang S, Johnston K, Ravandi-Kashani F, Levis M, van Nooten F (2017) Health-related quality of life of patients with acute myeloid leukemia: a systematic literature review. Oncol Ther 5(1):1\u201316","journal-title":"Oncol Ther"},{"issue":"2","key":"9888_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/cncr.10245","volume":"94","author":"D Cella","year":"2002","unstructured":"Cella D, Lai J, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528\u2013538","journal-title":"Cancer"},{"issue":"3","key":"9888_CR24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EMA Smets","year":"1995","unstructured":"Smets EMA, Garssen B, Bonke B, De Haes JCJM (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315\u2013325","journal-title":"J Psychosom Res"},{"issue":"2","key":"9888_CR25","doi-asserted-by":"publisher","first-page":"E91","DOI":"10.1188\/15.ONF.E91-E101","volume":"42","author":"AL Bryant","year":"2015","unstructured":"Bryant AL, Walton AL, Shaw-Kokot J, Mayer DK, Reeve BB (2015) Patient-reported symptoms and quality of life in adults with acute leukemia: a systematic review. Oncol Nurs Forum 42(2):E91\u2013101","journal-title":"Oncol Nurs Forum"},{"issue":"4","key":"9888_CR26","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00432-022-03995-2","volume":"149","author":"R Tober","year":"2023","unstructured":"Tober R, Schnetzke U, Fleischmann M, Yomade O, Schrenk K, Hammersen J et al (2023) Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia. J Cancer Res Clin Oncol 149(4):1569\u20131583","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"9888_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1182\/hematology.2020000098","volume":"2020","author":"C Logan","year":"2020","unstructured":"Logan C, Koura D, Taplitz R (2020) Updates in infection risk and management in acute leukemia. Hematology 2020(1):135\u2013139","journal-title":"Hematology"},{"issue":"5","key":"9888_CR28","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ajh.27625","volume":"100","author":"S Shimony","year":"2025","unstructured":"Shimony S, Stahl M, Stone RM (2025) Acute myeloid leukemia: 2025 update on diagnosis, risk-stratification, and management. Am J Hematol 100(5):860\u2013891","journal-title":"Am J Hematol"},{"issue":"11","key":"9888_CR29","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1007\/s00277-024-05963-x","volume":"103","author":"SK Prajapati","year":"2024","unstructured":"Prajapati SK, Kumari N, Bhowmik D, Gupta R (2024) Recent advancements in biomarkers, therapeutics, and associated challenges in acute myeloid leukemia. Ann Hematol 103(11):4375\u20134400","journal-title":"Ann Hematol"},{"issue":"5","key":"9888_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","volume":"45","author":"M Forsberg","year":"2024","unstructured":"Forsberg M, Konopleva M (2024) AML treatment: conventional chemotherapy and emerging novel agents. Trends Pharmacol Sci 45(5):430\u2013448","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"9888_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/bjh.16708","volume":"190","author":"J Loke","year":"2020","unstructured":"Loke J, Lowe DM, Miller LJ, Morton S, Roy NBA, Sekhar M et al (2020) Supportive care in the management of patients with acute myeloid leukaemia: where are the research needs? Br J Haematol 190(3):311\u2013313","journal-title":"Br J Haematol"},{"key":"9888_CR32","doi-asserted-by":"publisher","unstructured":"Chan RJ, Knowles R, Ashbury FD, Bowen J, Chan A, Chin M et al (2024) Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care\u2014an international Delphi study. EClinicalMedicine 76:102825. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102825","DOI":"10.1016\/j.eclinm.2024.102825"},{"issue":"5","key":"9888_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1089\/jpm.2018.0462","volume":"22","author":"R Sullivan","year":"2019","unstructured":"Sullivan R, Ugalde A, Sinclair C, Breen LJ (2019) Developing a research agenda for adult palliative care: a modified delphi study. J Palliat Med 22(5):480\u2013488","journal-title":"J Palliat Med"},{"key":"9888_CR34","unstructured":"New South Wales Health, Centre for Epidemiology and Evidence (2023) Setting research priorities: a guide. Sydney, Australia: evidence and evaluation guidance series, population and public health division, NSW Ministry of Health, ISBN: 978-1-76023-706-6"},{"issue":"7","key":"9888_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032829","volume":"102","author":"Z Shang","year":"2023","unstructured":"Shang Z (2023) Use of Delphi in health sciences research: a narrative review. Medicine 102(7):e32829","journal-title":"Medicine"},{"issue":"5","key":"9888_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/NNR.0000000000000297","volume":"67","author":"S McPherson","year":"2018","unstructured":"McPherson S, Reese C, Wendler MC (2018) Methodology update: delphi studies. Nurs Res 67(5):404","journal-title":"Nurs Res"},{"key":"9888_CR37","unstructured":"Hsu CC, Sandford BA (n.d.) The Delphi technique: making sense of consensus. Available from: https:\/\/scholarworks.umass.edu\/pare\/vol12\/iss1\/10\/.\u00a0Accessed 12 Jan 2025"},{"issue":"1","key":"9888_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-37","volume":"5","author":"RB Akins","year":"2005","unstructured":"Akins RB, Tolson H, Cole BR (2005) Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 5(1):37","journal-title":"BMC Med Res Methodol"},{"issue":"15","key":"9888_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.14260\/jemds\/2020\/275","volume":"9","author":"S Alizadeh","year":"2020","unstructured":"Alizadeh S, Maroufi SS, Sohrabi Z, Norouzi A, Dalooei RJ, Ramezani G (2020) Large or small panel in the Delphi study? Application of bootstrap technique. jemds 9(15):1267\u20131271","journal-title":"jemds"},{"key":"9888_CR40","doi-asserted-by":"crossref","unstructured":"Staykova M (2019) Rediscovering the Delphi technique: a review of the literature. Adv Soc Sci Res J 6(1). [Internet]. Available from: http:\/\/scholarpublishing.org\/index.php\/ASSRJ\/article\/view\/5959. Accessed Jan 3 2025","DOI":"10.14738\/assrj.61.5959"},{"key":"9888_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/16094069211066170","volume":"20","author":"J Rowlands","year":"2021","unstructured":"Rowlands J (2021) Interviewee transcript review as a tool to improve data quality and participant confidence in sensitive research. Int J Qual Methods 20:160940692110661","journal-title":"Int J Qual Methods"},{"issue":"9","key":"9888_CR42","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE (2005) Three approaches to qualitative content analysis. Qual Health Res 15(9):1277\u20131288","journal-title":"Qual Health Res"},{"issue":"4","key":"9888_CR43","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM et al (2014) Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol 67(4):401\u2013409","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"9888_CR44","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1016\/j.clml.2017.07.009","volume":"17","author":"IA Malik","year":"2017","unstructured":"Malik IA, Cardenas-Turanzas M, Gaeta S, Borthakur G, Price K, Cortes J et al (2017) Sepsis and acute myeloid leukemia: a population-level study of comparative outcomes of patients discharged from Texas hospitals. Clin Lymphoma Myeloma Leuk 17(12):e27\u201332","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"9888_CR45","first-page":"CD004386","volume":"1","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie TA, van de Wetering MD et al (2012) Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev 1(1):CD004386","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"9888_CR46","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000742","volume":"6","author":"J Stemler","year":"2022","unstructured":"Stemler J, Cornely OA (2022) Antifungal prophylaxis in acute myeloid leukemia: new drugs, new challenges? summary of the EHA guideline on antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel-targeted therapies. HemaSphere 6(7):e742","journal-title":"HemaSphere"},{"issue":"19","key":"9888_CR47","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","volume":"368","author":"SJ Stanworth","year":"2013","unstructured":"Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L et al (2013) A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 368(19):1771\u20131780","journal-title":"N Engl J Med"},{"issue":"7","key":"9888_CR48","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1056\/NEJMoa0904084","volume":"362","author":"SJ Slichter","year":"2010","unstructured":"Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG et al (2010) Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 362(7):600\u2013613","journal-title":"N Engl J Med"},{"issue":"1","key":"9888_CR49","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jpainsymman.2017.08.030","volume":"55","author":"MJ Hochman","year":"2018","unstructured":"Hochman MJ, Yu Y, Wolf SP, Samsa GP, Kamal AH, LeBlanc TW (2018) Comparing the palliative care needs of patients with hematologic and solid malignancies. J Pain Symptom Manage 55(1):82\u201388.e1","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"9888_CR50","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jpainsymman.2010.12.008","volume":"42","author":"V Manitta","year":"2011","unstructured":"Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J (2011) The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage 42(3):432\u2013442","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"9888_CR51","volume":"31","author":"VM Yenson","year":"2023","unstructured":"Yenson VM, Amgarth-Duff I, Brown L, Caperchione CM, Clark K, Cross A et al (2023) Defining research priorities and needs in cancer symptoms for adults diagnosed with cancer: an Australian\/New Zealand modified Delphi study. Support Care Cancer 31(7):436","journal-title":"Support Care Cancer"},{"issue":"63","key":"9888_CR52","doi-asserted-by":"publisher","first-page":"102272","DOI":"10.1016\/j.ejon.2023.102272","volume":"1","author":"M Dowling","year":"2023","unstructured":"Dowling M, Efstathiou N, Drury A, Semple C, Fern\u00e1ndez-Ortega P, Brochstedt Dieperink K et al (2023) Cancer nursing research priorities: a rapid review. Eur J Oncol Nurs 1(63):102272","journal-title":"Eur J Oncol Nurs"},{"issue":"9","key":"9888_CR53","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1056\/NEJMp1109283","volume":"366","author":"MJ Barry","year":"2012","unstructured":"Barry MJ, Edgman-Levitan S (2012) Shared decision making \u2014 the pinnacle of patient-centered care. N Engl J Med 366(9):780\u2013781","journal-title":"N Engl J Med"},{"issue":"33","key":"9888_CR54","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1200\/JCO.2009.27.3698","volume":"28","author":"LE Carlson","year":"2010","unstructured":"Carlson LE, Groff SL, Maciejewski O, Bultz BD (2010) Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. JCO 28(33):4884\u20134891","journal-title":"JCO"},{"issue":"33","key":"9888_CR55","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1200\/JCO.2010.31.0136","volume":"28","author":"G Velikova","year":"2010","unstructured":"Velikova G (2010) Patient benefits from psychosocial care: screening for distress and models of care. JCO 28(33):4871\u20134873","journal-title":"JCO"},{"key":"9888_CR56","doi-asserted-by":"crossref","unstructured":"Smith TB, Workman C, Andrews C, Barton B, Cook M, Layton R, et al (2021) Effects of psychosocial support interventions on survival in inpatient and outpatient healthcare settings: a meta-analysis of 106 randomized controlled trials. Tsai AC, editor. PLoS Med 18(5):e1003595.","DOI":"10.1371\/journal.pmed.1003595"},{"issue":"11","key":"9888_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1200\/JCO.2011.39.5046","volume":"30","author":"PB Jacobsen","year":"2012","unstructured":"Jacobsen PB, Wagner LI (2012) A new quality standard: the integration of psychosocial care into routine cancer care. JCO 30(11):1154\u20131159","journal-title":"JCO"},{"issue":"2","key":"9888_CR58","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S1470-2045(11)70002-X","volume":"12","author":"AJ Mitchell","year":"2011","unstructured":"Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160\u2013174","journal-title":"Lancet Oncol"},{"issue":"10","key":"9888_CR59","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1002\/pon.4228","volume":"25","author":"L Grassi","year":"2016","unstructured":"Grassi L, Fujisawa D, Odyio P, Asuzu C, Ashley L, Bultz B et al (2016) Disparities in psychosocial cancer care: a report from the International Federation of Psycho-oncology Societies. Psychooncology 25(10):1127\u20131136","journal-title":"Psychooncology"},{"issue":"1","key":"9888_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S1040-8428(02)00021-5","volume":"45","author":"M Keller","year":"2003","unstructured":"Keller M, Weis J, Schumacher A, Griessmeier B (2003) Psycho-oncology in a united Europe\u2014changes and challenges. Crit Rev Oncol Hematol 45(1):109\u2013117","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"9888_CR61","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/pon.4044","volume":"26","author":"L Travado","year":"2017","unstructured":"Travado L, Reis JC, Watson M, Borr\u00e0s J (2017) Psychosocial oncology care resources in Europe: a study under the European Partnership for Action Against Cancer (EPAAC). Psychooncology 26(4):523\u2013530","journal-title":"Psychooncology"},{"issue":"6","key":"9888_CR62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/ajco.13922","volume":"19","author":"J Taylor","year":"2023","unstructured":"Taylor J, Fradgley EA, Clinton-McHarg T, Hall A, Paul CL (2023) Perceived importance of emotional support provided by health care professionals and social networks: should we broaden our focus for the delivery of supportive care? Asia-Pac J Clncl Oncology 19(6):681\u2013689","journal-title":"Asia-Pac J Clncl Oncology"},{"key":"9888_CR63","unstructured":"Australian New Zealand Clinical Trials Registry. AMLM22\/D1: the international acute myeloid leukaemia (AML) platform consortium (IAPC) trial is a randomised, multi-arm study platform to compare the efficacy of experimental therapies versus standard of care in patients with acute myeloid leukaemia in first complete remission. [Internet]. Available from: https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12619000248167. Accessed 2 Feb 2025"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09888-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T04:04:27Z","timestamp":1760673867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09888-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["9888"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09888-7","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Andrew Wei should not be associated with affiliation 3. The original article has been updated accordingly.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided consent, and the research was carried out in accordance with the Declaration of Helsinki. The study was reviewed by the Monash University Human Research and Ethics Committee (#41418).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"844"}}